Advertisement

Topics

Octapharma Company Profile

01:04 EDT 22nd September 2018 | BioPortfolio

Octapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality plasma derivatives.From its foundation in 1983 the company has grown to employ over 1482 people in 27 countries. Octapharma owns four modern, state-of-the-art production facilities in Austria, France, Sweden and Mexico. Since 2005 Octapharma also opperates the NSTOB plant in Springe Germany. Sales turnover in 2005 exceeded Euro 421 million

Location

Switzerland


News Articles [9 Associated News Articles listed on BioPortfolio]

Octapharma present new data on the benefits of Nuwiq® in patients with haemophilia A at the ...

Octapharma AGInternational Business Unit - HaematologyOlaf WalterOlaf.Walter@octapharma.comorLarisa BelyanskayaLarisa.Belyanskaya@octapharma.comTel: +41 55 4512121 Read more....

Octapharma Share Promising Preclinical Data for SubQ-8, a Novel Subcutaneous Recombinant FVIII, ...

Octapharma AGInternational Business Unit - HaematologyOlaf WalterOlaf.Walter@octapharma.comorLarisa BelyanskayaLarisa.Belyanskaya@octapharma.comTel: +41 55 4512121 Read more....

Chris Bombardier, First Hemophiliac to Climb the Seven Summits, Joins Octapharma USA at HFA Annual Symposium in Cleveland

Mountain Climber Will Discuss Mount Everest Climb, Upcoming Documentary One-on-One With Visitors of Octapharma Booth Hemophilia hero Chris Bombardier, who recently beca...

Octapharma USA Grant Supports National Conference for Type 3 von Willebrand Disease Patients

‘Making the Connection’ will be held June 22 – 25 in Palm Beach Gardens, Florida For the second year in a row, Octapharma USA will serve as the exclusive sponsor ...

Octapharma Share Promising Preclinical Data for SubQ-8, a Novel Subcutaneous Recombinant FVIII, at WFH 2018

Octapharma announced today that pre-clinical data for SubQ-8 were presented during a symposium at the recent World Federation of Hemophilia (WFH) 2018 World Congress in Glasgow, U...

Acquired Aplastic Anemia Market Exhibit a Considerable Growth at a CAGR of 7.6% Till 2023

Acquired Aplastic Anemia Market Key Players are Pfizer Inc. , Bayer AG , Novo Nordisk AS , Shire , SOBI , Octapharma , CSL Limited , Amgen Inc., GlaxoSmithKline plc., and Bluebird bio. Acquired Aplast...

Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A

Octapharma announced today that the European Medicines Agency (EMA) has approved an extension of marketing authorisation for its human cell line-derived recombinant factor VIII (r...

Octapharma AG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryOctapharma AG Octapharma is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with pro...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 5% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 5%. ALBUMIN (HUMAN) 5% For intravenous...

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 20% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 20%. ALBUMIN (HUMAN) 20% For intraven...

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 25% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 25%. ALBUMIN (HUMAN) 25% For intraven...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Intravenous immunoglobulin 10% in children with primary immunodeficiency diseases.

To assess the safety and efficacy of an intravenous immunoglobulin (IVIG) 10% preparation (Panzyga; Octapharma AG, Lachen, Switzerland) in predominantly antibody-deficient children with primary immuno...

Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study.

Intravenous immunoglobulin (IVIG) therapy is commonly used to treat patients with primary antibody deficiency. This prospective, open-label, non-randomised, multicentre, phase III trial investigated t...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment

Patients with primary or secondary immunodeficiency disease who have developed adverse reactions to products available on the market such as Cuvitru® (Shire), Hizentra® (CSL Behring) or ...

Companies [7 Associated Companies listed on BioPortfolio]

Octapharma AG

Octagam®10% is a liquid, 10% (100 mg/mL) immune globulin (human) solution for intravenous administration (IVIG) which is currently registered in European countries and expected...

Octapharma USA

Headquartered in Lachen, Switzerland, Octapharma is one of the largest plasma products manufacturers in the world and has been committed to patient care and medical innovation for over 25 years. Octap...

Octapharma Group

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and huma...

Octapharma

Octapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality plasma derivatives.From its foun...

Octapharma USA, Inc

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovat...

More Information about "Octapharma" on BioPortfolio

We have published hundreds of Octapharma news stories on BioPortfolio along with dozens of Octapharma Clinical Trials and PubMed Articles about Octapharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Octapharma Companies in our database. You can also find out about relevant Octapharma Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record